EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ashwagandha‐Induced Herb‐Induced Liver Injury Assessed With the Updated 2016 RUCAM

Samuel Pérez Pérez iD, Erika Zumaqué-Valverde iD, María Fernanda Saavedra Chacón iD, Ariel Antonio Arteta Cueto iD

Case Reports in Hepatology · 2026-01 · 2026 (1)

DOI: 10.1155/crhe/8417352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Hepatology, online erschienen am 29.07.2026. Verfasst von Samuel Pérez Pérez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastrohepatology Research Group, University of Antioquia, Medellín, Antioquia, Colombia, udea.edu.co. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ashwagandha‐induced herb‐induced liver injury (HILI) has increasingly been reported; however, many published cases show methodological variability in causality assessment and limited clinicopathological correlation. We present a case of ashwagandha‐associated liver injury with systematic causality evaluation using the updated 2016 Roussel Uclaf Causality Assessment Method (RUCAM) and comprehensive clinicopathological correlation. A previously healthy 27‐year‐old woman developed jaundice and generalized pruritus after consuming ashwagandha for three days. Infectious, autoimmune, and metabolic etiologies were excluded. Abdominal magnetic resonance imaging showed no structural abnormalities, while liver biopsy demonstrated a classic cholestatic pattern without fibrosis. Causality assessment using the updated 2016 RUCAM yielded a score of 7 points, consistent with probable HILI. The patient received symptomatic management, corticosteroids, and azathioprine, with progressive clinical and biochemical improvement. This case highlights the value of a systematic causality approach using updated RUCAM criteria together with complete clinicopathological correlation to strengthen diagnostic confidence in suspected HILI associated with herbal supplements.

Schlagwörter

Stichwörter der Autor:innen

Withania somniferacase reportshepatotoxicityherb-induced liver injury

Autor:innen und Institutionen

  • Gastrohepatology Research Group, University of Antioquia, Medellín, Antioquia, Colombia, udea.edu.co.
  • Departmet of Hepatology, Cancer Institute Las Americas, Auna, Medellin Antioquia, Colombia.
  • Department of Hepatology, CES Clinic, Medellín, Antioquia, Colombia.
  • Department of Pathology, University of Antioquia, Medellín, Antioquia, Colombia, udea.edu.co.
  • Pathology Research Group, University of Antioquia (GRIP-UdeA), Medellín, Antioquia, Colombia.
  • Pathology Laboratory, CES Clinic, Medellín, Antioquia, Colombia.

ORCID-Profile: Samuel Pérez Pérez, Erika Zumaqué-Valverde, María Fernanda Saavedra Chacón, Ariel Antonio Arteta Cueto

Zitieren

APA

Pérez Pérez, S., Zumaqué-Valverde, E., Saavedra Chacón, M. F., & Arteta Cueto, A. A. (2026). Ashwagandha‐Induced Herb‐Induced Liver Injury Assessed With the Updated 2016 RUCAM. Case Reports in Hepatology, 2026(1). https://doi.org/10.1155/crhe/8417352

Vancouver

Pérez Pérez S, Zumaqué-Valverde E, Saavedra Chacón MF, Arteta Cueto AA. Ashwagandha‐Induced Herb‐Induced Liver Injury Assessed With the Updated 2016 RUCAM. Case Reports in Hepatology. 2026;2026(1). doi:10.1155/crhe/8417352

BibTeX
@article{PrezPrez2026,
  author = {Pérez Pérez, Samuel and Zumaqué-Valverde, Erika and Saavedra Chacón, María Fernanda and Arteta Cueto, Ariel Antonio},
  title = {Ashwagandha‐Induced Herb‐Induced Liver Injury Assessed With the Updated 2016 RUCAM},
  journal = {Case Reports in Hepatology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crhe/8417352}
}
Kostenlos starten →